Physician profile
Mark Carreon
NPI 1063757573
$2,613.43
in general payments reported to CMS, 2019-2025
10 companies · $573 in 2025
The $573 reported for 2025 was more than what 76% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $254 · 2022: $728 · 2023: $717 · 2024: $341 · 2025: $573.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,631.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,631.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $979.35 | 2021-2024 | Tavneos, Parsabiv, Aranesp |
| Ardelyx, INC. | $383.87 | 2024-2025 | Xphozah 30 Mg, Ibsrela |
| Vifor Pharma, INC. | $325.82 | 2022-2023 | Veltassa |
| Akebia Therapeutics INC | $215.32 | 2025 | Vafseo |
| Sobi, INC | $187.38 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $186.03 | 2022-2023 | Farxiga |
| Nxstage Medical, INC. | $149.04 | 2022 | |
| Horizon Therapeutics Plc | $124.81 | 2023 | Krystexxa |
| Novartis Pharmaceuticals Corporation | $43.89 | 2025 | |
| Calliditas Therapeutics US INC. | $17.92 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Carreon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.